• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RIO

RIO TINTO LIMITED - Charts / Financials

1.35% ! $131.85
Market Cap $48.94B  !
Metals & Mining Industrial Metals & Minerals
Add to My Watchlist

Rio Tinto Limited is a mining and materials company. It operates in 35 countries and... Rio Tinto Limited is a mining and materials company. It operates in 35 countries and produces iron ore, copper, aluminum, critical minerals and other materials needed for the global energy transition. Its segments include Iron Ore, Aluminum, Copper, and Minerals. The iron ore segment includes iron ore mining and salt and gypsum production in Western Australia. Its iron ore operations in the Pilbara comprise an integrated network of 18 iron ore mines and four independent port terminals. The aluminum segment includes bauxite mining, alumina refining, and aluminum smelting and recycling. The copper segment includes mining and refining of copper, gold, silver, molybdenum, other by-products and licensing of extraction technologies. The minerals segment includes mining and processing of borates, diamonds, iron concentrate and pellets from the Iron Ore Company of Canada, lithium and titanium dioxide feedstock.More

refresh Created with Sketch. REFRESH
Day
Open $131.42   Day High $132.13   Day Low $130.35
Daily Volume 960320
Bids   Sellers
Number Price Volume   Number Price Volume
1 $131.81 550   1 $131.85 1000

Directors & Senior Management

Mr. Simon Trott Chief Executive Officer, Director
Mr. Peter Lloyd Cunningham Chief Financial Officer, Executive Director
Mr. Matthew Holcz Chief Executive - Iron Ore
Ms. Katie Jackson Chief Executive - Copper
Mr. Jerome X. Pecresse Chief Executive - Aluminium
Ms. Georgie Bezette Chief People Officer
Mr. Mark Davies Chief Technical Officer
Mr. Bold Baatar Chief Commercial Officer
Ms. Isabelle Deschamps Chief Legal Officer, Governance and Corporate Affairs
Mr. Tim A. Paine Company Secretary, Rio Tinto Limited
Mr. Dominic S. Barton Non-Executive Chairman of the Board
Mr. Benjamin Sana Wyatt Senior Independent Director
Mr. Dean Dalla Valle Independent Non-Executive Director
Ms. Susan J. Lloyd-Hurwitz Independent Non-Executive Director
Ms. Jennifer A. Nason Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$131.85 		Change
-1.800(1.35%) 		Mkt cap ! $48.94B
Open High Low Value Volume
$131.42 $132.13 $130.35 $126.3M 960.3K

Buyers (Bids)

No. Vol. Price($)
1 550 $131.81
 

Sellers (Offers)

Price($) Vol. No.
$131.85 1000 1
View Market Depth
Last trade - 16.14pm 14/11/2025 (20 minute delay) ?

Top Stories

Week 46 Wrap: I feel like the Santa Rally isn't going to happen this year either. Also, Simandou is here

Well, what a week it’s been. The ASX200 is back down to the 8,640s as I write this (at 2.25pm AEDT) and that means 1Y returns for the index are down to +5%. Not that long ago, the XJO was looking at YTD returns of +10% when the US-Australia critical minerals deal was the flavour o...
Which Aussie state is flipping the economic script in 2026? If you feel like you’re working harder but getting nowhere, you’re not imagining it. But what if there’s a place in Australia where your money stretches further, your career moves faster, and your chances of building real wealth genuinely improve? H...
Magnum Mining kicks off REE drilling at Azimuth Project in Brazil Magnum Mining (ASX:MGU) has kicked off drilling for rare earth elements (REEs) at its Azimuth Project in Brazil where the company’s now got auger rigs spinning as the geotech team kicks off early-stage surface drillworks. Listen to the HotCopper podcast for in-depth discussions an...
PYC reports Phase II success in treating degenerative blindness condition PYC Therapeutics (ASX:PYC) has reported its investigational drug candidate, VP-001, has shown success in patients with Retinitis Pigmentosa type 11 (RP11) in Phase 1/2 clinical trials where improvements were reported by patients for up to 18 months after treatment. Listen to the HotCopper podcast...
HotCopper Highlights: Droneshield, what the hell? Plus MinRes' $1B steal; Life360 & more Good Afternoon and welcome to HotCopper Highlights for Week 46, I’m Jon Davidson. In this segment the stocks you were watching and discussing the most this week, for better or worse @ let’s get into it starting with the most viewed.Listen to the HotCopper podcast f...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.